SCHEMBL4021374

SCHEMBL4021374

COc1ccc(-c2ncccc2-c2nn[nH]c2O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.57
▸ ALDH1A1 P00352 4/20 0.57
▸ HPGD P15428 2/20 0.57
▸ CLK4 Q9HAZ1 1/20 0.43
▸ CCNE2 O96020 2/20 0.41
▸ CDK4 P11802 2/20 0.41
▸ CCND1 P24385 2/20 0.41
▸ CCNE1 P24864 2/20 0.41
▸ CDK2 P24941 2/20 0.41
▸ KCNA5 P22460 1/20 0.40
▸ NPC1 O15118 3/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ NFKB1 P19838 1/20 0.40
▸ NFKB2 Q00653 1/20 0.40
▸ RELA Q04206 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4026201 0.83 PTGS1 (0.42) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL28047038 0.83 ALDH1A1 (0.47) KDM4EALDH1A1HPGDNPC1RAB9A
SCHEMBL7113110 0.78 KDM4E (0.67) KDM4EALDH1A1HPGDCLK4KCNA5
SCHEMBL23397418 0.74 ALDH1A1 (0.61) KDM4EALDH1A1HPGDCLK4CDK2
SCHEMBL5313883 0.74 KDM4E (1.00) KDM4EALDH1A1HPGDCLK4CCNE2
SCHEMBL5330253 0.70 KDM4E (0.65) KDM4EALDH1A1HPGDCLK4KCNA5
SCHEMBL935169 0.69 ALDH1A1 (0.67) KDM4EALDH1A1HPGDCLK4KCNA5
SCHEMBL15638866 0.68 TGFBR1 (0.60) KDM4EALDH1A1HPGDCLK4CDK2
SCHEMBL16048953 0.68 KDM4E (0.66) KDM4EALDH1A1HPGDCLK4KCNA5
SCHEMBL8486254 0.68 PTGS2 (0.74) KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613617-A4 DI-ARYL SUBSTITUTED TRIAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO INC (US) 2009-02-18 — — EP disclosed
EP-1613617-A2 DI-ARYL SUBSTITUTED TRIAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 Merck & Co., Inc. (US) 2006-01-11 — — EP disclosed
EP-1458708-A4 HETEROARYL SUBSTITUTED TRIAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO INC (US) 2005-11-16 — — EP disclosed
WO-2004089306-A2 DI-ARYL SUBSTITUTED TRIAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO., INC. (US) 2004-10-21 — — WO disclosed
EP-1458708-A2 HETEROARYL SUBSTITUTED TRIAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 Merck & Co., Inc. (US) 2004-09-22 — — EP disclosed
WO-2003051315-A2 HETEROARYL SUBSTITUTED TRIAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO., INC. (US) 2003-06-26 — — WO disclosed
Send feedback